BIOMAT Database Logo BIOMAT Database Logo

The role of melatonin in patients with chronic kidney disease undergoing haemodialysis. 2012

Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, Rhodes, Greece. gaperis@yahoo.com

Patients with chronic kidney disease including those undergoing haemodialysis have deranged sleep-wake pattern. In large part this is due to an abnormal circadian cycle of melatonin, a hormone secreted by the pineal gland in the evening and induces sleep. Subjects undergoing automated peritoneal dialysis or nocturnal haemodialysis have better sleep profile compared to those on daytime dialysis. Studies have shown that exogenous melatonin improves sleep-wake cycle in daytime haemodialysis patients. However, large randomised controlled trials are needed in order to establish its role in this patient population.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D020178 Sleep Disorders, Circadian Rhythm Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel (e.g., JET LAG SYNDROME), shift work, or other causes. Circadian Rhythm Sleep Disorder,Circadian Rhythm Sleep Disorders,Nonorganic Sleep Wake Cycle Disorder,Shift-Work Sleep Disorder,Sleep-Wake Cycle Disorder,Sleep-Wake Cycle Disorders,Sleep-Wake Schedule Disorder,Advanced Sleep Phase Syndrome,Delayed Sleep Phase Syndrome,Delayed Sleep-Phase Syndrome,Disturbed Nyctohemeral Rhythm,Non-24 Hour Sleep-Wake Disorder,Nonorganic Sleep Wake Cycle Disorders,Sleep Disorder, Shift-Work,Sleep-Wake Disorder, Non-24 Hour,Sleep-Wake Schedule Disorders,Delayed Sleep-Phase Syndromes,Disturbed Nyctohemeral Rhythms,Non 24 Hour Sleep Wake Disorder,Nyctohemeral Rhythm, Disturbed,Nyctohemeral Rhythms, Disturbed,Shift Work Sleep Disorder,Shift-Work Sleep Disorders,Sleep Disorder, Shift Work,Sleep Disorders, Shift-Work,Sleep Wake Cycle Disorder,Sleep Wake Cycle Disorders,Sleep Wake Disorder, Non 24 Hour,Sleep Wake Schedule Disorder,Sleep Wake Schedule Disorders

Related Publications

Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Active deprescribing program in chronic kidney disease patients undergoing haemodialysis.
November 2021, Nephrology (Carlton, Vic.),
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Identification of salivary peptidomic biomarkers in chronic kidney disease patients undergoing haemodialysis.
February 2019, Clinica chimica acta; international journal of clinical chemistry,
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
April 2012, International journal of clinical practice,
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Cognitive Impairment and its Correlates in Chronic Kidney Disease Patients Undergoing Haemodialysis.
January 2019, Journal of evolution of medical and dental sciences,
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Renalase in Haemodialysis Patients with Chronic Kidney Disease.
February 2021, Journal of clinical medicine,
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Prevalence and patterns of hearing loss among chronic kidney disease patients undergoing haemodialysis.
January 2015, The Australasian medical journal,
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
The role of melatonin treatment in chronic kidney disease.
June 2012, Frontiers in bioscience (Landmark edition),
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Assessing burden and its determinants in caregivers of chronic kidney disease patients undergoing haemodialysis.
January 2021, Open journal of psychiatry & allied sciences,
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis.
March 2013, Nephrology (Carlton, Vic.),
Georgios Aperis, and Preeth Prakash, and Christos Paliouras, and Nikolaos Papakonstantinou, and Polichronis Alivanis
Association Of Quality Of Sleep With Cognitive Decline Among The Patients Of Chronic Kidney Disease Undergoing Haemodialysis.
January 2017, Journal of Ayub Medical College, Abbottabad : JAMC,
Copied contents to your clipboard!